Therefore, it can be speculated that Rg3 can inhibit the interaction between tumor cells and CAFs by downregulating TGF-β secretion of tumor cells and the subsequent TGF-β/Smad signaling of CAFs. This evidence concerns the gene TGFB1 and neoplasm.